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Objective: It has been reported that the lectin-like oxidized low-density lipoprotein (Ox-LDL) receptor 1
(LOX-1) is expressed by chondrocytes in osteoarthritis (OA) cartilage and that Ox-LDL binding to LOX-1
increases intracellular oxidative stress in cultured bovine articular chondrocytes (BACs). It was recently
demonstrated that reactive oxygen species (ROS) induce hypertrophic differentiation of chondrocytes in
the growth plate. It has also been shown that activated chondrocytes in OA have hypertrophic chon-
drocyte-like phenotypes. The purpose of this study was to determine whether Ox-LDL induces hyper-
trophic chondrocyte-like phenotypes in BACs.
Design: Changes in type X collagen (COL10) and runt-related transcription factor 2 (Runx2) mRNA
expression in BACs after Ox-LDL stimulation were investigated using real-time polymerase chain reaction
(PCR). Western blotting and immunoﬂuorescent cell staining were used to investigate changes in protein
level. The antioxidant N-acetyl cysteine (NAC) was used to ascertain whether oxidative stress is involved
in COL10 and Runx2 expression. We induced LOX-1 knockdown cells using small interfering RNA (siRNA)
to examine the receptor speciﬁcity of Ox-LDL.
Results: COL10 expression was upregulated by Ox-LDL in a time- and dose-dependent manner.
Immunoﬂuorescent staining showed that Ox-LDL increased COL10 production in the extracellular matrix.
Ox-LDL-induced upregulation of COL10 was suppressed by pretreatment with NAC and siRNA. Expression
of Runx2 was upregulated by Ox-LDL and H2O2, and these effects were suppressed by NAC pretreatment.
Conclusion: Ox-LDL binding to LOX-1 induces a hypertrophic chondrocyte-like phenotype through
oxidative stress, indicating that Ox-LDL plays a role in the degeneration of cartilage.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Under physiologic conditions, articular chondrocytes maintain
a stable phenotype to retain their function as a permanent carti-
lage. Differentiation of chondrocytes is strictly regulated so that the
cartilage does not undergo ossiﬁcation through hypertrophic
differentiation, as is the case with endochondral bone formation1.
Meanwhile, formation of clusters of activated and proliferating
chondrocytes is a hallmark in the early phase of osteoarthritis (OA)
cartilage2. These activated chondrocytes are hypertrophic in sizeMasao Akagi, Department of
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s Research Society International. Pand exhibit sustained functional and phenotypic changes, including
an increase in expression of type X collagen (COL10), runt-related
transcription factor 2 (Runx2), vascular endothelial growth factor
(VEGF) and matrix metalloproteinase-13 (MMP-13), and in alkaline
phosphatase (ALP) activity, which indicates that chondrocytes in
OA cartilage assume the characteristics of hypertrophic chon-
drocytes in growth plate cartilage3e5.
Hypertrophic chondrocytes, terminally differentiated chon-
drocytes in the growth plate that induce endochondral ossiﬁcation,
destroy the cartilage matrix via MMP expression, introduce
vascular channels and bone cells from the bone marrow to the
cartilage, and eventually cause apoptosis6. It was recently reported
that reactive oxygen species (ROS) induce chondrocyte hyper-
trophy in the growth plate and plays a key role in endochondral
ossiﬁcation7. On the other hand, it has also been reported that
intracellular oxidative stress participates in cartilage degeneration
in OA8e10. Taken together, these results indicate that oxidative
stress, which may be induced by many mechanisms in OA, causesublished by Elsevier Ltd. All rights reserved.
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cells, resulting in degeneration of cartilage because of cartilage
matrix degradation and cell death.
Oxidized low-density lipoprotein (Ox-LDL) is one of the most
important molecules that cause atherosclerosis11. A novel receptor
for Ox-LDL, designated lectin-like Ox-LDL receptor 1 (LOX-1), was
recently cloned from cultured bovine aortic endothelial cells12. Ox-
LDL uptake through this receptor, which is expressed on the
vascular endothelium, is critically involved in endothelial activation
and dysfunction in atherogenesis13. In vivo14e16 and in vitro17
studies suggest that lipid peroxidation is involved in cartilage
degeneration associated with aging and in the pathogenesis of OA.
Some epidemiologic studies have suggested that OA and athero-
sclerosis share a common epidemiologic background in terms of
the involvement of lipid peroxidation18,19.
Nakagawa et al. showed that LOX-1 is expressed by chondrocytes
and Ox-LDL is present in chondrocytes in rat zymosan-induced
arthritis (ZIA) and that treatment with an anti-LOX-1 blocking
antibody suppresses articular cartilage degeneration in ZIA, sug-
gesting that Ox-LDL binding to LOX-1 is involved in cartilage
degeneration20. It has been shown thatOx-LDL is present in synovial
ﬂuid from human OA joints and that LOX-1 mRNA and protein are
expressed in chondrocytes derived from human OA21,22. Akagi et al.
further demonstrated that the presence of Ox-LDL and the expres-
sion of LOX-1 in chondrocytes are correlated with the degenerative
grade of OA cartilage22. This accumulating evidence suggests that
the Ox-LDL/LOX-1 system plays a role in cartilage degeneration.
We previously demonstrated that Ox-LDL binding to LOX-1
induces ROS generation in cultured bovine articular chondrocytes
(BACs), indicating that Ox-LDL increases intracellular oxidative
stress in chondrocytes24. In this study, we investigated whether
Ox-LDL binding to LOX-1 enhances differentiation of cultured BACs
and induces hypertrophic chondrocyte-like phenotypes through an
increase in intracellular oxidative stress. First, we observed that the
formation of chondrocytic nodules was enhanced by Ox-LDL and
investigated whether Ox-LDL increases ALP activity and COL10
expression. Next, we investigated whether the antioxidant N-acetyl
cysteine (NAC) affects Ox-LDL-induced COL10 and Runx2 expres-
sion. We then produced LOX-1 knockdown cells using siRNA to
examine the receptor speciﬁcity of Ox-LDL.Methods
Reagents
Anti-COL10 mouse IgM antibody and anti-Runx2 mouse IgG
antibody were purchased from Abcam plc (Cambridge, UK) and
used as primary antibodies forWestern blotting. Anti-COL10 rat IgG
antibody was purchased from Cosmo Bio Co. (Tokyo, Japan) and
used as a primary antibody for immunoﬂuorescence. Anti-mouse
IgM and anti-mouse IgG horseradish peroxidase-linked antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA)
and used as secondary antibodies for COL10 and Runx2 Western
blotting, respectively. Anti-rat IgG antibody labeled with Texas Red
was purchased from Santa Cruz Biotechnology. The method used to
prepare native LDL and Ox-LDL was described previously12.Culture of BACs
Chondrocytes were isolated from articular cartilage of
10-month-old cows by digestion with 0.08% collagenase (Wako
Pure Chemical Industries, Osaka, Japan) for 6 h at 37 C. After
ﬁltration, cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (Gibco, Grand Island, NY) supplemented with 200 U/ml ofpenicillin, 40 mg/ml of streptomycin, and 10% fetal bovine serum at
37 C in a humidiﬁed hypoxic atmosphere (5% O2 and CO2).
Observation of chondrocytic nodules
Cells were cultured in a monolayer until conﬂuence and for 96 h
thereafter. Chondrocytes formed characteristic nodules as previ-
ously reported25,26. The cultures were observed using a phase-
contrast microscope and the number of chondrocytic nodules per
ﬁeld under 100-fold magniﬁcation was counted. The mean
numbers of nodules for ﬁve randomly selected ﬁelds per dish were
used for analysis.
Measurement of ALP activity
The ALP activities of cultured BACs were measured using
a substrate reaction and development method (Tracp & Alp Assay
Kit, Takara Bio, Shiga, Japan). Chondrocytes were seeded into a 96-
well plate at a density of 2104 cells per well in 200 ml of culture
medium. Phosphate-buffered saline (PBS), 10 mg/ml of native LDL,
10 mg/ml of Ox-LDL, or 10 nM bonemorphogenic protein-2 (BMP-2)
were added to the mediumwhen conﬂuence was reached. After 14
days, the culture medium was removed and each well was rinsed
three times with physiologic saline. A volume of 50 ml of physiologic
saline containing 1% polyoxyethylene (9) octylphenyl ether (NP)
was added to eachwell and the cells were lysedwith stirring. Buffer
solution (0.2 M tris-hydroxymethyl-aminomethane triseHCl con-
taining MgCl2) was added and the cell lysate was reacted with the
substrate (p-nitro-phenyl phosphate) at 37 C for 60 min. NaOH
(50 ml 0.9 N NaOH) was added to stop the reaction and absorbance
at 405 nm was measured using a microplate reader (Model 680;
Bio-Rad, Hercules, CA).
Extraction of COL10 and Runx2 mRNA and real-time polymerase
chain reaction (PCR)
Chondrocytes (5105) were pelleted in 1.5 ml microtubes. The
cells were resuspended in 350 ml of RNeasy lysis buffer (RNeasy
plus MINI Kit; Qiagen, Valencia, CA). RNA was extracted using
RNeasy columns according to the manufacturer’s instructions.
Extracted RNA was eluted in 30 ml of RNase-free water. Single-
strand complementary DNA (cDNA) was prepared from total RNA
using a random primer under standard conditions and a High
Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Foster, CA). The cDNA from each sample was diluted and used to
quantify the expression of COL10 and Runx2.
Quantitative real-time PCR of total cDNA was performed using
Perfect Real-time SYBR Green II (Takara Bio, Shiga, Japan) and the
following primer sets: for b-actin, 50-GGTCATCACCATTGGCAATG-30
(forward) and 50-CCACAGGACTCCATGCCC-30 (reverse); for COL10,
50-TTCTTCATCCCGTATGCCA-30 (forward) and 50-GGTGGACCAGG-
GATGCC-30 (reverse); for Runx2, 50-ACTGGCGCTGCAACAAGAC-30
(forward) and 50-CAGTCCCATCTGGTACCTCTCC-30 (reverse); and for
LOX-1, 50-TGGCAAGACAGCAAAAGGTT-30 (forward) and 50-CCAGA-
CAAAGGACCCCTAGAGT-30 (reverse). The primer sets were designed
to span exons to distinguish cDNA from genomic DNA products.
PCR ampliﬁcations were performed using the ABI7700 real-time
PCR system (Applied Biosystems, Foster, CA) under the following
conditions: 95 C for 10 s, followed by 40 cycles of 95 C for 5 s and
60 C for 30 s. To quantify the relative expression of each gene, Ct
values were normalized against the endogenous reference (DCt¼ Ct
target e Ct b-actin) and were compared with a calibrator using the
DDCt method (DDCt¼DCt sampleDCt calibrator). We used the
average Ct value for untreated chondrocytes as a calibrator. All
H. Kishimoto et al. / Osteoarthritis and Cartilage 18 (2010) 1284e12901286experiments included negative controls, which consisted of no
cDNA for each primer pair.
Observation of extracellular COL10 using immunoﬂuorescence
Cells were seeded at a density of 2104 in 35 mm plates. When
they reached conﬂuence, 10 mg/ml of Ox-LDL was added and cells
were cultured for 48 h. The plates were rinsed with PBS and the
cells were ﬁxed in 10% formalin for 60 min at room temperature.
After ﬁxation, the plates were washed twice in PBS. After blocking
for 30 min, the plates were incubated with the primary antibody
against COL10 overnight at 4 C and were then incubated with
a secondary antibody labeled with Texas Red for 60 min at room
temperature. The plates were rinsed in PBS containing 40,6-dia-
midino-2-phenylindole (DAPI) to counterstain nuclei and the cells
were observed using a ﬂuorescence microscope (Biorevo BZ-9000,
Keyence, Osaka, Japan).
Western blot analysis
Cultured BACs and extracellular matrix were collected into
1.5 ml microtubes. Chondrocytes were lysed in a lysis buffer
(Sample Buffer Solution, Wako Pure Industries, Osaka, Japan) and
boiled for 5 min. The supernatant was subjected to Western blot-
ting. Cell lysates were separated using 10% sodium dodecyl sulfate
polyacrylamide gel electrophoresis and the proteins were trans-
ferred onto a polyvinylidene ﬂuoride membrane using an iBlot gel
transfer system (Invitrogen, Auckland, New Zealand). After block-
ing, the membrane was incubated overnight at 4 C with the
primary antibody, incubated at room temperature with the
secondary antibody for 1 h, and then visualized using an ECL Plus
Western blot detection system (Amersham Biosciences, Little
Chalfont, UK). For quantiﬁcation, signal intensities were measured
using an Image Quant TL system (Amersham Biosciences, LittleFig. 1. Phase-contrast microscopy of chondrocytic nodules. After reaching conﬂuence, BACs
observed using a phase-contrast microscope (see text).Chalfont, UK) and the intensities of the COL10 protein bands
relative to those of the actin bands were analyzed using image
analysis software and expressed as a ratio of that of the control.
Preparation of LOX-1 knockdown cells using small interfering RNA
Cells were seeded in a 48-well plate at a density of 2104 cells
per well. When they reached 50% conﬂuence, the BACs were
incubated with the following siRNA sets: sequence 1, ccaaaugg-
caagacagcaaTT and anti-sequence 1, uugcugucuugccauuuggTT;
sequence 2, caaaagaaggcgaaucuauTT and anti-sequence 2, aua-
gauucgccuucuuuugTT; and sequence 3, cuaagaacuuguugccuaaTT
and anti-sequence 3, uuaggcaaguucuuagTT. After 48 h, RNA was
extracted and transcribed to cDNA using the methods mentioned
previously. The suppression efﬁciency of LOX-1 mRNA expression
was 12.8 5.5% (N¼ 4) with this siRNA, which was conﬁrmed by
the real-time PCR method mentioned above.
Statistical analysis
Results are presented as the mean, 95% conﬁdence interval (CI),
and standard deviation (SD). Student’s t-tests, Dunnett tests and
TurkeyeKramer tests were used for statistical assessments.
Results
Chondrocytic nodular formation in cultured BACs
Culture dishes in which BACs had reached conﬂuence were
observed using a phase-contrast microscope 96 h after addition of
PBS (control) or 10 mg/ml Ox-LDL. Although BACs clumped and
formed chondrocytic nodules under both conditions, the
nodules were larger for the Ox-LDL treatment than for the control
[Fig. 1(AeD)]. In nodule peripheries, cell sizes of BACs incubatedwere incubated with PBS (control, A and B) or 10 mg/ml Ox-LDL (C and D) for 96 h and
Fig. 2. Effects of Ox-LDL on COL10 mRNA and protein expression. BACs were incubated
with 10 mg/ml of Ox-LDL or PBS. COL10 mRNA expression at the indicated times was
investigated using real-time PCR. Error bars indicate standard deviations (N¼ 5) (A).
BACs were incubated with the indicated concentrations of Ox-LDL or 10 nM of BMP-2
for 48 h, and COL10 protein expression was investigated using Western blotting (B).
The results of quantiﬁcation of relative intensities of the COL10 protein bands are
shown in Table II.
Table II
Expression of COL10 mRNA and protein
Mean folds of control 95% CI P-value
COL 10 mRNA/actin (real-time PCR): N¼ 6
Control 1.00 e e
n-LDL 10 mg/ml 1.13 0.99e1.27 0.9940
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nodule centers, meanwhile, cell sizes of BACs incubated with
Ox-LDL appeared to be rather smaller than those of control cells
(Fig. 1B and D). Inwhole ﬁelds of microscopy, obvious differences in
the chondrocyte morphology could not be noted between groups.
The mean number of the nodules per ﬁeld under 100-fold magni-
ﬁcation for the Ox-LDL treatment and that for the control was 10.50
(95% CI; 6.71e14.29) and 3.25 (95% CI; 1.73e4.77), respectively
(P¼ 0.0013, N¼ 4).
Effects of Ox-LDL on ALP activity
ALP activity was measured 14 days after addition of 10 mg of
Ox-LDL to conﬂuent BACs. Ox-LDL signiﬁcantly increased ALP
activity compared with the control. Addition of 10 nM of BMP-2
(positive control) also increased ALP activity compared with the
control, but 10 mg of addition of native LDL did not increase ALP
activity (Table I).
Effects of Ox-LDL on COL10 expression
The effect of Ox-LDL on COL10 mRNA expression was ﬁrst
investigated using real-time PCR. After reaching conﬂuence, BACs
were incubatedwith 10 mg/ml of Ox-LDL for 0,12, 24, or 48 h. COL10
mRNA expression increased in a time-dependent manner (Fig. 2A).
BACs were then incubated for 48 h with Ox-LDL concentrations of
0, 5, 10, or 50 mg/ml. COL10 mRNA expression increased in a dose-
dependent manner. Addition of 10 nM of BMP-2 (positive control)
signiﬁcantly increased COL10 mRNA expression compared with the
control, but addition of native LDL did not increase COL10 mRNA
expression (Table II). Next, the effects of Ox-LDL on COL10 protein
expression were investigated using Western blotting. BACs were
incubated for 48 h with Ox-LDL concentrations of 0, 5, 10, or 50 mg/
ml. COL10 protein expression increased in a dose-dependent
manner (Fig. 2), which was conﬁrmed by the Image quantiﬁcation.
Addition of 10 nM of BMP-2 (positive control) signiﬁcantly
increased COL10 protein expression compared with the control
(Table II).
Observation of extracellular COL10 production using
immunoﬂuorescence microscopy
After reaching conﬂuence, BACs were incubated with 10 mg/ml
of Ox-LDL for 48 h. A mesh pattern of Texas Red, which is indicative
of the production of COL10 in the extracellular matrix, was
observed when 10 mg/ml of Ox-LDL was added, but little Texas Red
staining was observed with the control (Fig. 3).
Effects of NAC on Ox-LDL- and H2O2-induced COL10 expression
BACs were incubated with 10 mg/ml of Ox-LDL for 48 h and with
10 mM of H2O2 for 30 min and then cultured for 48 h. mRNA
expressionwas investigated using real-time PCR. COL10 expression
signiﬁcantly increased after treatment with Ox-LDL and H2O2,Table I
Effects of OX-LDL on ALP activities (N¼ 6)
ALP activity
(mean folds of control)
95% CI P-value
Control 1.00 0.56e1.44 e
n-LDL 10 mg/ml 1.15 0.84e1.86 0.3717
Ox-LDL 10 mg/ml 2.00 1.86e2.15 0.0017
BMP-2 10 nM 2.13 1.55e2.71 0.0050
CI: conﬁdence interval, n-LDL: native LDL.respectively, compared with the control (Table III). The effects of
pretreatment with 100 nM of NAC on Ox-LDL- and H2O2-induced
COL10mRNA expressionwere then investigated. Pretreatmentwith
100 nM of NAC signiﬁcantly suppressed the Ox-LDL- and H2O2-
induced increase in COL10 mRNA expression (Table III).
Western blotting analysis of COL10 expression yielded results
similar to those of real-time PCR, viz, Ox-LDL and H2O2 increased
COL10 expression at the protein level. Pretreatment with 100 nM of
NAC suppressed the Ox-LDL- and H2O2-induced increases in COL10
protein expression [Fig. 4(A)].
Effects of LOX-1 knockdown on COL10 mRNA expression
We used LOX-1 knockdown cells to examine the receptor
speciﬁcity of Ox-LDL. LOX-1 siRNA downregulated LOX-1 mRNA
expression in cultured BACs by 12.3% (95% CI; 7.8e16.8, P¼ 0.0014,
N¼ 4). The cells were seeded in a 48-well plate at a density of
2104 cells per microliter, cultured to 50% conﬂuence, and thenOx-LDL 5 mg/ml 1.52 1.20e1.04 0.4244
10 mg/ml 2.21 1.82e2.61 0.0062
50 mg/ml 2.45 1.36e3.55 0.0010
BMP-2 10 nM 3.34 2.57e4.11 <0.0001
COL10 protein/actin (Western blot): N¼ 4
Control 1.00 e e
Ox-LDL 5 mg/ml 145 0.88e2.03 0.6394
10 mg/ml 2.11 1.53e2.65 0.0487
50 mg/ml 2.52 1.36e3.67 0.0068
BMP-2 10 nM 3.03 1.54e4.51 0.0006
CI: conﬁdence interval, n-LDL native LDL.
Fig. 3. Immunoﬂuorescence analysis of Ox-LDL-induced extracellular COL10 production. After reaching conﬂuence, BACs were incubated with PBS or 10 mg/ml of Ox-LDL for 48 h.
Texas Red and DAPI were used for ﬂuorescence microscopy of COL10 protein and nuclei, respectively. The experiments were repeated twice with similar results.
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sion was not detected in the control under these conditions.
Consequently, BACs that were not treated with siRNA were incu-
bated with 10 mg/ml of Ox-LDL for 48 h and used as a calibrator for
COL10 mRNA in the real-time PCR analysis. When 10 mg/ml of
Ox-LDL was added to the LOX-1 knockdown cells, COL10 mRNA
expression decreased to 31.3% of that of the calibrator (95%CI;
16.1e48.3, P¼ 0.0043, N¼ 4). LOX-1 knockdown did not suppress
COL10 mRNA expression in BACs upregulated by H2O2 addition
(Table IV).Upregulation of Runx2 mRNA expression in BACs by Ox-LDL and
H2O2 and effects of NAC on OX-LDL- and H2O2-induced Runx2
expression
Runx2 expression was signiﬁcantly increased by Ox-LDL and
H2O2 comparedwith the control. Pretreatment with 100 nM of NACTable III
Effects of NAC on Ox-LDL- and H2O2-induced COL10 and Runx2 mRNA (N¼ 4)
NAC treatment P-value
() (þ)
Mean folds of
control (95% CI)
Mean folds of
control (95% CI)
COL 10 mRNA/actin (real-time PCR)
Control 1.05 (0.58e1.52) ND e
Ox-LDL 10 mg/ml 2.61 (2.02e3.20) 0.98 (0.73e1.23) 0.0001
H2O2 10 mm 3.05 (2.50e3.60) 1.15 (0.79e1.52) 0.0001
Runx2 mRNA/actin (real-time PCR)
Control 1.01 (0.79e1.22) 0.34 (0.72e0.95) 0.0785
Ox-LDL 10 mg/ml 2.53 (1.65e3.42) 1.08 (0.69e1.47) 0.0032
H2O2 10 mM 2.60 (1.50e3.69) 1.62 (1.44e1.81) 0.0280
MAC: N-acetyl cysteine, CI: conﬁdence interval. MD: not detected.suppressed the increase in Runx2 mRNA in BACs incubated with
10 mg/ml of Ox-LDL or 10 mM of H2O2 (Table III).
Western blotting analysis of Runx2 protein expression yielded
results similar to those for real-time PCR, viz, Ox-LDL and H2O2
increased Runx2 expression at the protein level. Pretreatment with
100 nM of NAC signiﬁcantly suppressed the Ox-LDL- and H2O2-
induced increase in Runx2 protein expression [Fig. 4(B)].Discussion
During monolayer culture, chondrocytes exhibit a temporal
pattern of gene expression: type II collagen is expressed ﬁrst, fol-
lowed by expression of aggrecan, COL10, and ALP, which shows that
the differentiation of chondrocytes proceeds toward ossiﬁcation27.
This order of gene expression is promoted by growth factors such asFig. 4. Effects of NAC on Ox-LDL- and H2O2-induced COL10 and Runx2 protein
expression. The effects of pretreatment with 100 nM of NAC on Ox-LDL- and H2O2-
induced COL10 (A) and Runx2 (B) protein expression in these cells were investigated
using Western blotting. Four experiments were repeated with similar results.
Table IV
Effects of LOX-1 knockdown on Ox-LDL-induced COL10 mRNA expression (N¼ 4)
LOX-1 siRNA treatment P-value
() (þ)
Mean folds of Ox-LDL
10 mg/ml (95% CI)
Mean folds of Ox-LDL
10 mg/ml (95% CI)
COL10 mRNA/actin (real-time PCR)
Control ND ND e
Ox-LDL 10 mg/ml 1.03 (0.65e1.41) 0.31 (0.21e0.42) 0.0043
H2O2 10 mm 2.97 (1.89e4.06) 3.25 (1.99e4.50) 0.6623
CI: conﬁdence interval, ND: not detected.
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reaching conﬂuence in a monolayer culture, these chondrocytes
cluster together and form nodules29. We varied some culture
conditions for experimental purposes in this study. Chondrocytic
nodule formation was observed 96 h after addition of Ox-LDL,
when the difference between experimental and control groups was
most signiﬁcant. For the ALP activity, a culture period day 14 was
chosen because it has been shown to elevate in the late phase of
endochondral ossiﬁcation. To facilitate experiments, we chose the
shortest culture period (48 h) when we can observe enough
increase in the COL10 and Runx2 expression.
Cell sizes of BACs in nodule peripheries incubated with Ox-LDL
appeared to be larger than those of control cells. In the nodule
centers, meanwhile, cell sizes were rather smaller than those of
control cells, suggesting that chondrocytes may be undergoing cell
death23. Further, Ox-LDL increased the numbers and sizes of
chondrocytic nodules. These ﬁndings indicate that Ox-LDL could
promote differentiation of chondrocytes toward ossiﬁcation and to
induce the hypertrophic chondrocyte-like phenotype observed in
OA cartilage.
COL10 is a characteristic marker of hypertrophic chondrocytes
in the growth plate30, and is a marker of hypertrophic chondrocyte-
like cells in OA cartilage3e5. In our study, Ox-LDL increased the
expression of COL10 and the activity of ALP in a dose-dependent
manner, whereas native LDL and culture medium did not, sug-
gesting that Ox-LDL promotes hypertrophic differentiation in OA
cartilage. In LOX-1 knockdown cells, Ox-LDL-induced upregulation
of COL10 mRNA expression was suppressed compared with that of
the control. This indicates that LOX-1 plays, at least partly, a role as
a receptor for Ox-LDL in inducing hypertrophic chondrocyte-like
phenotypes.
It was recently reported that intracellular ROS induce chon-
drocyte hypertrophy in endochondral ossiﬁcation7. On the other
hand, many investigators have reported that oxidative stress causes
dysfunction of articular chondrocytes and degeneration of cartilage
in OA8e10,31. We previously demonstrated that Ox-LDL binding to
LOX-1 induces production of intracellular ROS and increases
intracellular oxidative stress in BACs24. The results of the present
study showed that both Ox-LDL and H2O2 upregulate COL10
expression in cultured BACs, and that NAC, an antioxidant,
suppresses the effect of Ox-LDL and H2O2 on COL10 expression. This
suggests that Ox-LDL-induced oxidative stress plays an important
role in the upregulation of COL10 expression.
The molecular mechanisms responsible for hypertrophic
differentiation of chondrocytes and COL10 expression have been
investigated by many researchers. Runx2 is essential for differen-
tiation of osteoblasts, hypertrophic chondrocyte maturation, and
COL10 expression32,33. Expression of matrix breakdown enzymes,
including MMPs and aggrecanases, is increased in hypertrophic
chondrocyte-like cells in human OA cartilage34 and mouse
experimental OA cartilage35, both of which are involved in the
degeneration of articular cartilage. It was recently reported thatRunx2þ/mice with knee joint instability showed a decrease in the
rate of OA change and had reduced COL10 and MMP-13 expression
compared with wild-type mice4, indicating that Runx2 contributes
to the pathogenesis of OA through chondrocyte hypertrophy and
matrix breakdown. Consequently, we investigated the effect of Ox-
LDL on Runx2 expression in cultured BACs. Runx2 expression was
upregulated by Ox-LDL and H2O2, and these effects were sup-
pressed by pretreatment with NAC. This indicates that oxidative
stress induced Runx2 expression, which is consistent with the
ﬁndings of another study7. Therefore, Ox-LDL-induced intracellular
ROS may upregulate expression of Runx2, which in turn induce
hypertrophic phenotype in chondrocytes.
In conclusion, we propose a mechanism for the involvement of
Ox-LDL in the development of OA in which Ox-LDL-induced
oxidative stress causes pathologic hypertrophic differentiation of
articular chondrocytes through Runx2 upregulation, following
which the activated chondrocytes upregulate the hypertrophic cell
markers, COL10 and ALP. We have previously demonstrated in vitro
that Ox-LDL upregulates another hypertrophic chondrocyte
marker, VEGF, by binding to LOX-136. Furthermore, we have
recently observed that Ox-LDL upregulates MMP-13 expression
(data not shown). The Ox-LDL/LOX-1 system may play a role in the
pathogenesis of OA.
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